ClinicalTrials.Veeva

Menu

Effect of Bio-activation on Epithelial and Connective Cell Adhesion to Titanium Abutments: Split Mouth Clinical Trial

U

University of Genoa (UniGe)

Status

Not yet enrolling

Conditions

Missing Tooth/Teeth

Treatments

Device: the test group were placed in an Argon plasma reactor

Study type

Interventional

Funder types

Other

Identifiers

NCT07069231
Abutment adhesion

Details and patient eligibility

About

The aim of this "in vivo" controlled trial is to assess soft tissue cell adhesion to titanium abutments subjected to different cleaning procedures - no treatment (as they come from the industry), and cleaning by plasma- at an early healing time.

In fact, the primary aim is Quantity and Quality of soft tissue adhesion at the microscopic level (e.g Fibronectin, Integrin-actin).

The secondary Aim - Clinical parameters and outcomes - BOP, PPD, MBL (Marginal Bone Level to check influence of plasmapp-treated abutments).

The null hypothesis of the study was that the cleaning procedure applied to implant abutments has no effect on soft tissue cell adhesion and MBL at an early healing time.

Enrollment

20 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • presence of at least 4 mm of keratinized mucosa around the implants,
  • patients aged 18 years or older
  • medically healthy patients (ASA I), or patients with mild systemic disease (ASA II)
  • Total or partial edentulous state with space for at least 2 implants

Exclusion criteria

  • ASA physical status 3
  • severe smokers (> 10 cig/day)
  • patients undergoing bisphosphonate therapy
  • pregnant or lactating women
  • estrogen-related hormonal disorders or hormonal substitution therapy patients with a history of head and neck cancers and radiotherapy in this region

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

20 participants in 2 patient groups

Machined Abutment - control
No Intervention group
Description:
The control group received MUA without plasma treatment.
Plasma abutment - test
Experimental group
Description:
.The MUA allocated to the test group will be placed in a plasma reactor (Plasmapp, South Korea) for decontamination and activation of the surface. In order to restrict any post-treatment contamination; abutments will be inserted immediately after the end of the plasma process.
Treatment:
Device: the test group were placed in an Argon plasma reactor

Trial contacts and locations

0

Loading...

Central trial contact

Luigi Canullo

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems